Claims for Patent: 8,221,566

Summary for Patent: 8,221,566

Title:	Process for employing HNFX as a biocidal explosive
Abstract:	A process of making detonation products having an effect on biological agents, providing an effective amount of HNFX; combining HNFX with an additive; detonating the combination with a detonation device; creating detonation products from the combination; contacting the detonation products with the harmful agents; exposing the detonation products for about at least 2 seconds to harmful agents; and destroying the harmful agents.
Inventor(s):	Chapman; Robert D. (Ridgecrest, CA)
Assignee:	The United States of America as represented by the Secretary of the Navy (Washington, DC)
Application Number:	12/615,918
Patent Claims:	1. A process of making detonation products having an effect on biological agents, comprising: providing an effective amount of HNFX; detonating said HNFX with a detonation device; creating detonation products from said HNFX; contacting the detonation products with the biological agents; exposing said detonation products for about at least 2 seconds to biological agents; and destroying the biological agents. 2. The process according to claim 1, further comprising combining said HNFX with an additive. 3. The process according to claim 1, wherein said exposing of said detonation products to the biological agents is for about at least 15 minutes. 4. The process according to claim 1, wherein said exposing of said detonation products to the biological agents is for about at least 20 minutes. 5. The process according to claim 1, wherein said detonation products comprises of at least atomic fluorine. 6. The process according to claim 1, wherein said detonation products comprises of at least hydrogen fluoride. 7. The process according to claim 1, wherein said detonation products comprises of at least atomic fluorine and hydrogen fluoride. 8. The process according to claim 1, wherein said detonation products destroy biological agents which comprises of at least one of Bacillus anthracis, Bacillus subtilis, and Bacillus thuringiensis. 9. The process according to claim 1, wherein said detonation products destroy biological agents which comprises of at least one of Vibrio cholera, Yersinia pestis, Franciscella tularensis, and Brucellosis suis. 10. The process according to claim 1, wherein said effective amount of HFNX is about 97%. 11. The process according to claim 2, wherein said additive is a desensitiser. 12. The process according to claim 2, where said additive is about 3%. 13. A method of producing a biocide, comprising: detonating an N,N-dihaloamine explosive compound to produce a biocidal atomic fluorine derivative. 14. A method of producing a biocide, comprising: detonating an N,N-dihaloamine explosive compound to produce a biocidal atomic fluorine derivative, wherein said N,N-dihaloamine explosive compound which comprises of at least HNFX. 15. A method of producing a biocide, comprising: detonating a N,N-dihaloamine explosive compound to produce biocidal hydrogen fluoride. 16. A method of producing a biocide, comprising: detonating a N,N-dihaloamine explosive compound to produce biocidal hydrogen fluoride, wherein said N,N-dihaloamine explosive compound which comprises of at least HNFX.

Details for Patent 8,221,566

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Emergent Biodefense Operations Lansing Llc	BIOTHRAX	anthrax vaccine adsorbed	Injection	103821	11/12/1998		2029-07-02